Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin

We studied the effect of quercetin on ovarian adenocarcinoma SKOV-3 cell line and isogenic subline SKOV-3/CDDP resistant to the anticancer drug cisplatin. It was found that in resistant cells, quercetin in a concentration of 100 μM that causes a decrease in the cell viability suppressed the expressi...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 2022-10, Vol.173 (6), p.760-764
Main Authors: Hasan, A. A. Sh, Kalinina, E. V., Tatarskiy, V. V., Volodina, Yu. L., Petrova, А. S., Novichkova, M. D., Zhdanov, D. D., Shtil, A. A.
Format: Article
Language:English
Subjects:
1-Phosphatidylinositol 3-kinase
Adenocarcinoma
AKT protein
Antioxidants
Antitumor agents
Apoptosis
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer cells
Cell Biology
Cell cycle
Cell viability
Chemotherapy
Cisplatin
Drug resistance
Enzymes
Flavonoids
Free radicals
Gene expression
Genes
Internal Medicine
Kinases
Laboratory Medicine
Ovaries
Pathology
Quercetin
Signal transduction
Software
TOR protein
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923
cites cdi_FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923
container_end_page 764
container_issue 6
container_start_page 760
container_title Bulletin of experimental biology and medicine
container_volume 173
creator Hasan, A. A. Sh
Kalinina, E. V.
Tatarskiy, V. V.
Volodina, Yu. L.
Petrova, А. S.
Novichkova, M. D.
Zhdanov, D. D.
Shtil, A. A.
description We studied the effect of quercetin on ovarian adenocarcinoma SKOV-3 cell line and isogenic subline SKOV-3/CDDP resistant to the anticancer drug cisplatin. It was found that in resistant cells, quercetin in a concentration of 100 μM that causes a decrease in the cell viability suppressed the expression of genes encoding the key antioxidant enzymes ( SOD2 , CAT , GPX1 , and HO-1 ), transcription factor Nrf2, and kinases of the PI3K/Akt/mTOR signaling pathway. In parental cells, quercetin, on the contrary, increased the expression of these genes. The results confirm the redox-dependent regulation induced by quercetin and its opposite nature in cisplatin-sensitive and cisplatin-resistant cancer cells.
doi_str_mv 10.1007/s10517-022-05626-9
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2731427410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A736593498</galeid><sourcerecordid>A736593498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhgdRcK3-Aa8Cgngz3XzNZnK5DFaLhdZuvQ5pcmY3dSYZkwy6_nqzXaFWRHIREp73IYe8VfWa4FOCsVgmghsiakxpjZsVXdXySbUgjWB1Syl5Wi1woWretu3z6kVKd4cjXpFF9XMzT1OElFzwKPQo7wCtfXbhh7PaZ7TZpwwj0t6iq3P2abn-mpfjzeU12rit14PzW3Sl8-673iPnUefSNOjsfH0NyaV8MHTaG4iog2FI6HaPPs8QDRTmZfWs10OCV7_3k-rL2fub7mN9cfnhvFtf1IY3ONdcUs0s4UYKfmuFMJoYSfoeMxDWUCo4YNlbIzDWlBCwxGpiJectpoZIyk6qd0fvFMO3GVJWo0umPEd7CHNSVDDCi4bggr75C70Lcyxz3lOsbYpPPFBbPYByvg85anOQqrVgq0YyLttCnf6DKsvC6Ezw0Lty_yjw9o_ADvSQdykMc_kMnx6D9AiaGFKK0KspulHHvSJYHeqgjnVQpQ7qvg5KlhA7hlKB_Rbiw2j_Sf0CCtO1Sg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2733851927</pqid></control><display><type>article</type><title>Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin</title><source>Springer Nature</source><creator>Hasan, A. A. Sh ; Kalinina, E. V. ; Tatarskiy, V. V. ; Volodina, Yu. L. ; Petrova, А. S. ; Novichkova, M. D. ; Zhdanov, D. D. ; Shtil, A. A.</creator><creatorcontrib>Hasan, A. A. Sh ; Kalinina, E. V. ; Tatarskiy, V. V. ; Volodina, Yu. L. ; Petrova, А. S. ; Novichkova, M. D. ; Zhdanov, D. D. ; Shtil, A. A.</creatorcontrib><description>We studied the effect of quercetin on ovarian adenocarcinoma SKOV-3 cell line and isogenic subline SKOV-3/CDDP resistant to the anticancer drug cisplatin. It was found that in resistant cells, quercetin in a concentration of 100 μM that causes a decrease in the cell viability suppressed the expression of genes encoding the key antioxidant enzymes ( SOD2 , CAT , GPX1 , and HO-1 ), transcription factor Nrf2, and kinases of the PI3K/Akt/mTOR signaling pathway. In parental cells, quercetin, on the contrary, increased the expression of these genes. The results confirm the redox-dependent regulation induced by quercetin and its opposite nature in cisplatin-sensitive and cisplatin-resistant cancer cells.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-022-05626-9</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>1-Phosphatidylinositol 3-kinase ; Adenocarcinoma ; AKT protein ; Antioxidants ; Antitumor agents ; Apoptosis ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Cancer cells ; Cell Biology ; Cell cycle ; Cell viability ; Chemotherapy ; Cisplatin ; Drug resistance ; Enzymes ; Flavonoids ; Free radicals ; Gene expression ; Genes ; Internal Medicine ; Kinases ; Laboratory Medicine ; Ovaries ; Pathology ; Quercetin ; Signal transduction ; Software ; TOR protein</subject><ispartof>Bulletin of experimental biology and medicine, 2022-10, Vol.173 (6), p.760-764</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>COPYRIGHT 2022 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923</citedby><cites>FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hasan, A. A. Sh</creatorcontrib><creatorcontrib>Kalinina, E. V.</creatorcontrib><creatorcontrib>Tatarskiy, V. V.</creatorcontrib><creatorcontrib>Volodina, Yu. L.</creatorcontrib><creatorcontrib>Petrova, А. S.</creatorcontrib><creatorcontrib>Novichkova, M. D.</creatorcontrib><creatorcontrib>Zhdanov, D. D.</creatorcontrib><creatorcontrib>Shtil, A. A.</creatorcontrib><title>Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><description>We studied the effect of quercetin on ovarian adenocarcinoma SKOV-3 cell line and isogenic subline SKOV-3/CDDP resistant to the anticancer drug cisplatin. It was found that in resistant cells, quercetin in a concentration of 100 μM that causes a decrease in the cell viability suppressed the expression of genes encoding the key antioxidant enzymes ( SOD2 , CAT , GPX1 , and HO-1 ), transcription factor Nrf2, and kinases of the PI3K/Akt/mTOR signaling pathway. In parental cells, quercetin, on the contrary, increased the expression of these genes. The results confirm the redox-dependent regulation induced by quercetin and its opposite nature in cisplatin-sensitive and cisplatin-resistant cancer cells.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>Adenocarcinoma</subject><subject>AKT protein</subject><subject>Antioxidants</subject><subject>Antitumor agents</subject><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Cancer cells</subject><subject>Cell Biology</subject><subject>Cell cycle</subject><subject>Cell viability</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>Drug resistance</subject><subject>Enzymes</subject><subject>Flavonoids</subject><subject>Free radicals</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Internal Medicine</subject><subject>Kinases</subject><subject>Laboratory Medicine</subject><subject>Ovaries</subject><subject>Pathology</subject><subject>Quercetin</subject><subject>Signal transduction</subject><subject>Software</subject><subject>TOR protein</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kl1rFDEUhgdRcK3-Aa8Cgngz3XzNZnK5DFaLhdZuvQ5pcmY3dSYZkwy6_nqzXaFWRHIREp73IYe8VfWa4FOCsVgmghsiakxpjZsVXdXySbUgjWB1Syl5Wi1woWretu3z6kVKd4cjXpFF9XMzT1OElFzwKPQo7wCtfXbhh7PaZ7TZpwwj0t6iq3P2abn-mpfjzeU12rit14PzW3Sl8-673iPnUefSNOjsfH0NyaV8MHTaG4iog2FI6HaPPs8QDRTmZfWs10OCV7_3k-rL2fub7mN9cfnhvFtf1IY3ONdcUs0s4UYKfmuFMJoYSfoeMxDWUCo4YNlbIzDWlBCwxGpiJectpoZIyk6qd0fvFMO3GVJWo0umPEd7CHNSVDDCi4bggr75C70Lcyxz3lOsbYpPPFBbPYByvg85anOQqrVgq0YyLttCnf6DKsvC6Ezw0Lty_yjw9o_ADvSQdykMc_kMnx6D9AiaGFKK0KspulHHvSJYHeqgjnVQpQ7qvg5KlhA7hlKB_Rbiw2j_Sf0CCtO1Sg</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Hasan, A. A. Sh</creator><creator>Kalinina, E. V.</creator><creator>Tatarskiy, V. V.</creator><creator>Volodina, Yu. L.</creator><creator>Petrova, А. S.</creator><creator>Novichkova, M. D.</creator><creator>Zhdanov, D. D.</creator><creator>Shtil, A. A.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20221001</creationdate><title>Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin</title><author>Hasan, A. A. Sh ; Kalinina, E. V. ; Tatarskiy, V. V. ; Volodina, Yu. L. ; Petrova, А. S. ; Novichkova, M. D. ; Zhdanov, D. D. ; Shtil, A. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>Adenocarcinoma</topic><topic>AKT protein</topic><topic>Antioxidants</topic><topic>Antitumor agents</topic><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Cancer cells</topic><topic>Cell Biology</topic><topic>Cell cycle</topic><topic>Cell viability</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>Drug resistance</topic><topic>Enzymes</topic><topic>Flavonoids</topic><topic>Free radicals</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Internal Medicine</topic><topic>Kinases</topic><topic>Laboratory Medicine</topic><topic>Ovaries</topic><topic>Pathology</topic><topic>Quercetin</topic><topic>Signal transduction</topic><topic>Software</topic><topic>TOR protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasan, A. A. Sh</creatorcontrib><creatorcontrib>Kalinina, E. V.</creatorcontrib><creatorcontrib>Tatarskiy, V. V.</creatorcontrib><creatorcontrib>Volodina, Yu. L.</creatorcontrib><creatorcontrib>Petrova, А. S.</creatorcontrib><creatorcontrib>Novichkova, M. D.</creatorcontrib><creatorcontrib>Zhdanov, D. D.</creatorcontrib><creatorcontrib>Shtil, A. A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasan, A. A. Sh</au><au>Kalinina, E. V.</au><au>Tatarskiy, V. V.</au><au>Volodina, Yu. L.</au><au>Petrova, А. S.</au><au>Novichkova, M. D.</au><au>Zhdanov, D. D.</au><au>Shtil, A. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><date>2022-10-01</date><risdate>2022</risdate><volume>173</volume><issue>6</issue><spage>760</spage><epage>764</epage><pages>760-764</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><abstract>We studied the effect of quercetin on ovarian adenocarcinoma SKOV-3 cell line and isogenic subline SKOV-3/CDDP resistant to the anticancer drug cisplatin. It was found that in resistant cells, quercetin in a concentration of 100 μM that causes a decrease in the cell viability suppressed the expression of genes encoding the key antioxidant enzymes ( SOD2 , CAT , GPX1 , and HO-1 ), transcription factor Nrf2, and kinases of the PI3K/Akt/mTOR signaling pathway. In parental cells, quercetin, on the contrary, increased the expression of these genes. The results confirm the redox-dependent regulation induced by quercetin and its opposite nature in cisplatin-sensitive and cisplatin-resistant cancer cells.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s10517-022-05626-9</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2022-10, Vol.173 (6), p.760-764
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_miscellaneous_2731427410
source Springer Nature
subjects 1-Phosphatidylinositol 3-kinase
Adenocarcinoma
AKT protein
Antioxidants
Antitumor agents
Apoptosis
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer cells
Cell Biology
Cell cycle
Cell viability
Chemotherapy
Cisplatin
Drug resistance
Enzymes
Flavonoids
Free radicals
Gene expression
Genes
Internal Medicine
Kinases
Laboratory Medicine
Ovaries
Pathology
Quercetin
Signal transduction
Software
TOR protein
title Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A29%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20of%20the%20Antioxidant%20System%20and%20PI3K/Akt/mTOR%20Signaling%20Pathway%20in%20Cisplatin-Resistant%20Cancer%20Cells%20by%20Quercetin&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Hasan,%20A.%20A.%20Sh&rft.date=2022-10-01&rft.volume=173&rft.issue=6&rft.spage=760&rft.epage=764&rft.pages=760-764&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-022-05626-9&rft_dat=%3Cgale_proqu%3EA736593498%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-492a3d14c974bd77ca1c91ff03e7dc2274e09fdc700a211ed1da1d944802c1923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2733851927&rft_id=info:pmid/&rft_galeid=A736593498&rfr_iscdi=true